Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test

• Conditions: Colorectal Cancer

• Registration Number: NCT05172713
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

In France, colorectal cancer (CRC) is the second leading cause of cancer death. Its organized screening (Organized ColoRectal Cancer Screening: DOCCR), now carried out by immunological test for occult blood in the stool, has proven its effectiveness. When the immunological test is positive, the Haute Autorité de Santé recommends a total colonoscopy. In 5 to 10% of cases, this colonoscopy is incomplete. The renewal of the endoscopic procedure or the performance of additional second-line examinations are then recommended. At present, however, the respective place of second-line examinations to be performed in this situation is not the subject of specific and validated recommendations.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-16
• Status Verified: 2021-10
• Study First Submitted: 2021-10-13
• Study First Submitted QC: 2021-12-10
• Last Update Submitted: 2021-12-10
• Study First Posted: 2021-12-29
• Last Update Posted: 2021-12-29
• Primary Completion: 2022-04
• Study Completion: 2022-04-16

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective study of the patient outcomes who had an incomplete colonoscopy after a positive immunological fecal test	Files analysed retrospectively from January 01, 2018 to December 31, 2018 will be examined]

Trial Locations

Locations (1)

Service Hépato-Gastroentérologie et Assistance Nutritive - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France